11 β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammationSTAAB, Claudia A; MASER, Edmund.Journal of steroid biochemistry and molecular biology. 2010, Vol 119, Num 1-2, pp 56-72, issn 0960-0760, 17 p.Article

Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamilyHOFFMANN, Frank; MASER, Edmund.Drug metabolism reviews (Softcover ed.). 2007, Vol 39, Num 1, pp 87-144, issn 0360-2532, 58 p.Article

Identification and Characterization of the LysR-Type Transcriptional Regulator HsdR for Steroid-Inducible Expression of the 3α-Hydroxysteroid Dehydrogenase/Carbonyl Reductase Gene in Comamonas testosteroniWENJIE GONG; GUANGMING XIONG; MASER, Edmund et al.Applied and environmental microbiology (Print). 2012, Vol 78, Num 4, pp 941-950, issn 0099-2240, 10 p.Article

Two-dimensional gel electrophoresis : a powerful method to elucidate cellular responses to toxic compoundsMÖLLER, Anja; SOLDAN, Michael; VÖLKER, Uwe et al.Toxicology (Amsterdam). 2001, Vol 160, Num 1-3, pp 129-138, issn 0300-483XArticle

The novel anticancer drug oracin : Different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11 β-hydroxysteroid dehydrogenase type 1WSOL, Vladimir; SZOTAKOVA, Barbora; SKALOVA, Lenka et al.Toxicology (Amsterdam). 2004, Vol 197, Num 3, pp 253-261, issn 0300-483X, 9 p.Article

Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1 C3NOVOTNA, Romana; WSOL, Vladimir; GUANGMING XIONG et al.Toxicology letters. 2008, Vol 181, Num 1, pp 1-6, issn 0378-4274, 6 p.Article

Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liverBREYER-PFAFF, Ursula; MARTIN, Hans-Jörg; ERNST, Michael et al.Drug metabolism and disposition. 2004, Vol 32, Num 9, pp 915-922, issn 0090-9556, 8 p.Article

Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in manWSOL, Vladimir; SZOTAKOVA, Barbora; MARTIN, Hans-Joerg et al.Toxicology (Amsterdam). 2007, Vol 238, Num 2-3, pp 111-118, issn 0300-483X, 8 p.Article

Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: Effects of genistein, quercetin and buthionine-sulfoximineKLAUSER, Ellen; GÜLDEN, Michael; MASER, Edmund et al.Food and chemical toxicology. 2014, Vol 67, pp 212-221, issn 0278-6915, 10 p.Article

Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cellsSEIBERT, Hasso; MASER, Edmund; SCHWEDA, Kathrin et al.Food and chemical toxicology. 2011, Vol 49, Num 9, pp 2398-2407, issn 0278-6915, 10 p.Article

The Comamonas testosteroni steroid biosensor system (COSS): Reflection on other methodsMASER, Edmund; GUANGMING XIONG.Journal of steroid biochemistry and molecular biology. 2010, Vol 121, Num 3-5, pp 633-640, issn 0960-0760, 8 p.Article

Understanding oligomerization in 3 α-hydroxy steroid dehydrogenase/carbonyl reductase from Comamonas testosteroni : An in silico approach and evidence for an active proteinHOFFMANN, Frank; SOTRIFFER, Christoph; EVERS, Andreas et al.Journal of biotechnology. 2007, Vol 129, Num 1, pp 131-139, issn 0168-1656, 9 p.Article

THCVA-A ― A new additional marker for illegal cannabis consumptionRADÜNZ, Lars; WESTPHAL, Folker; MASER, Edmund et al.Forensic science international. 2012, Vol 215, Num 1-3, pp 171-174, issn 0379-0738, 4 p.Conference Paper

Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancersVERMA, Malkhey; MARTIN, Hans-Joerg; HAQ, Wahajul et al.European journal of pharmacology. 2008, Vol 584, Num 2-3, pp 213-221, issn 0014-2999, 9 p.Article

Genome Sequence of Comamonas testosteroni ATCC 11996, a Representative Strain Involved in Steroid DegradationWENJIE GONG; KISIELA, Michael; SCHILHABEL, Markus B et al.Journal of bacteriology. 2012, Vol 194, Num 6, pp 1633-1634, issn 0021-9193, 2 p.Article

Purification and characterization of akr1b10 from human liver : Role in carbonyl reduction of xenobioticsMARTIN, Hans-Jörg; BREYER-PFAFF, Ursula; WSOL, Vladimir et al.Drug metabolism and disposition. 2006, Vol 34, Num 3, pp 464-470, issn 0090-9556, 7 p.Article

Evidence of metyrapone reduction by two Mycobacterium strains shown by ¹H NMRCOMBOURIEU, Bruno; BESSE, Pascale; SANCELME, Martine et al.Biodegradation (Dordrecht). 2004, Vol 15, Num 2, pp 125-132, issn 0923-9820, 8 p.Article

Approaching clinical proteomics: current state and future fields of application in fluid proteomics : Proteomics and biomarkersAPWEILER, Rolf; ASLANIDIS, Charalampos; MEWES, Hans-Werner et al.Clinical chemistry and laboratory medicine. 2009, Vol 47, Num 6, pp 724-744, issn 1434-6621, 21 p.Article

Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracinSKARYDOVA, Lucie; SKARKA, Adam; NOVOTNA, Romana et al.Toxicology (Amsterdam). 2009, Vol 264, Num 1-2, pp 52-60, issn 0300-483X, 9 p.Article

Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human LiverKASSNER, Nina; HUSE, Klaus; WOJNOWSKI, Leszek et al.Drug metabolism and disposition. 2008, Vol 36, Num 10, pp 2113-2120, issn 0090-9556, 8 p.Article

Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitroSKALOVA, Lenka; NOBILIS, Milan; SZOTAKOVA, Barbora et al.Biochemical pharmacology. 2002, Vol 64, Num 2, pp 297-305, issn 0006-2952Article